Medroxyprogesterone vs Bupropion: side-by-side comparison
Medroxyprogesterone (Progestin) and Bupropion (Norepinephrine-dopamine reuptake inhibitor (NDRI) antidepressant) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Medroxyprogesterone | Bupropion |
|---|---|---|
| Therapeutic class | Progestin | Norepinephrine-dopamine reuptake inhibitor (NDRI) antidepressant |
| CAS | 520-85-4 | 34911-55-2 |
| ATC | G03DA02 | N06AX12 |
| Molecular weight | 344.49 g/mol | 239.74 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Medroxyprogesterone and Bupropion share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Medroxyprogesterone acts by a different mechanism than Bupropion, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Medroxyprogesterone: La médroxyprogestérone se lie aux récepteurs de la progestérone et exerce de puissants effets progestatifs : épaississement de la glaire cervicale, inhibition de l'ovulation, amincissement de l'endomètre et réduction des… Bupropion: Le bupropion inhibe la recapture de la noradrénaline et de la dopamine, avec un effet nettement plus faible sur la recapture de la sérotonine.
Indications compared
Medroxyprogesterone: La médroxyprogestérone est autorisée dans l'aménorrhée, les saignements utérins anormaux d'origine hormonale, la prévention de l'hyperplasie endométriale chez la femme ménopausée recevant un estrogène, et la prévention d… Bupropion: Le bupropion est autorisé dans la dépression caractérisée, la prévention des récidives de trouble affectif saisonnier et le sevrage tabagique.
Safety profile
Medroxyprogesterone: Les effets indésirables fréquents de la forme orale comprennent saignements irréguliers, tension mammaire, variations de l'humeur, rétention hydrique et prise de poids. Bupropion: Les effets indésirables fréquents comprennent sécheresse buccale, insomnie, céphalées, agitation, nausées et perte de poids.
Questions fréquentes
Is Medroxyprogesterone better than Bupropion? ▾
Medroxyprogesterone and Bupropion are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Medroxyprogesterone and Bupropion be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Medroxyprogesterone
Products with Bupropion
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.